- Sales -4% and EBIT -1% vs. ABGSCe - Organic growth of +1%, below ABGSCe +5% - Likely to see margin...
- Pre-announces Q3 sales 5% below ABGSCe... - ... and ~7% below on adj.
- 9% organic growth (ABG 9%) and EBITA -6% vs ABG - Positive development in all markets, Systems gre...
- Q3 pre-announced, outlook encouraging but dependent on OEMs - Consensus could lower '24e-'25e EBIT...
- Q3 report out on 8 November, 07:00 CET - '24e-'26 sales and EBIT ests.
- Sales -6%, adj. EBITA +5% vs cons in Q3 - Strong performance in product companies behind solid mar...
- Sales -2%, adj. EBITA +1% vs. cons, +3% org. growth - Consensus to raise '24e-'25e EBITA by 1-3% -...
- Mixed Q3, but with signs of improvements - We revise EBITDA down by 1.
- Order intake +2% y-o-y on return of one key customer - '25-'26e EBIT up 11-13% on higher gross mar...
- Both segments performed above our expectations in Q3 - EBIT up 2-1%, market to remain weak in H1'2...
- External manufacturing constinues to shine - We lower '24e-'26e EBITA by 2-1% - Share trading at 7...
- Q3 earnings miss reduces '24e EBIT, but order beat raises '25e - Market activity remains high and ...
EMS market has been weak but Incap was able to improve net sales in y/y and also in q/q basis.
MoveByBike AB (”MoveByBike eller ”Koncernen”) fortsätter att utöka reklamintäkter genom ett nytt sam...
Aixia fortsätter att skörda framgångar inom AI och lanserar nya finansiella mål.
Redeye increases its fair value range following a closer look at the report.
Relative profitability remained good but net sales declined by 19% in Q3 y/y driven by weak customer...
Redeye shares its initial comments on Heliospectra's Q3 results, noting that sales and cost base fig...
Operating currently in Finland and Sweden in the built environment consultancy sector, Solwers plans...
Redeye believes Sdiptech's Q3 report was weaker than expected, with continued positive organic sales...